GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MZF1
|
ENSG00000099326.4 | myeloid zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MZF1 | hg19_v2_chr19_-_59084647_59084721 | 0.42 | 9.6e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_61765315 | 24.96 |
ENST00000406957.1
ENST00000401558.2 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
chr17_+_4618734 | 24.50 |
ENST00000571206.1
|
ARRB2
|
arrestin, beta 2 |
chr4_-_84035905 | 20.71 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr4_-_84035868 | 19.47 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr17_-_47841485 | 19.23 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr16_+_69958887 | 19.20 |
ENST00000568684.1
|
WWP2
|
WW domain containing E3 ubiquitin protein ligase 2 |
chr11_-_46142615 | 17.57 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
chr12_-_15114603 | 15.95 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr11_-_46142948 | 15.85 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr1_-_153518270 | 15.11 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr14_+_75745477 | 14.89 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr19_-_39826639 | 14.52 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
chr17_+_4613776 | 14.00 |
ENST00000269260.2
|
ARRB2
|
arrestin, beta 2 |
chr17_+_4613918 | 13.68 |
ENST00000574954.1
ENST00000346341.2 ENST00000572457.1 ENST00000381488.6 ENST00000412477.3 ENST00000571428.1 ENST00000575877.1 |
ARRB2
|
arrestin, beta 2 |
chr12_-_15114492 | 13.44 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr5_+_137688285 | 13.23 |
ENST00000314358.5
|
KDM3B
|
lysine (K)-specific demethylase 3B |
chrX_-_135849484 | 13.14 |
ENST00000370620.1
ENST00000535227.1 |
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr6_-_86352982 | 12.52 |
ENST00000369622.3
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr6_-_32157947 | 12.16 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr2_+_219264466 | 12.12 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr17_+_38278826 | 12.05 |
ENST00000577454.1
ENST00000578648.1 ENST00000579565.1 |
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
chr16_-_28222797 | 11.46 |
ENST00000569951.1
ENST00000565698.1 |
XPO6
|
exportin 6 |
chr6_-_42016385 | 11.05 |
ENST00000502771.1
ENST00000508143.1 ENST00000514588.1 ENST00000510503.1 ENST00000415497.2 ENST00000372988.4 |
CCND3
|
cyclin D3 |
chr6_+_32936353 | 11.03 |
ENST00000374825.4
|
BRD2
|
bromodomain containing 2 |
chr1_-_150208498 | 10.57 |
ENST00000314136.8
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr6_-_32160622 | 10.56 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chrX_-_70474499 | 10.34 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
chr19_-_39108568 | 10.30 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr12_-_7077125 | 10.23 |
ENST00000545555.2
|
PHB2
|
prohibitin 2 |
chr19_+_35645817 | 10.17 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_+_35645618 | 10.16 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr9_+_131452239 | 9.72 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
chr5_+_49962495 | 9.57 |
ENST00000515175.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr5_-_81046841 | 9.47 |
ENST00000509013.2
ENST00000505980.1 ENST00000509053.1 |
SSBP2
|
single-stranded DNA binding protein 2 |
chr2_-_61697862 | 9.42 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
chr1_-_150208412 | 9.25 |
ENST00000532744.1
ENST00000369114.5 ENST00000369115.2 ENST00000369116.4 |
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr12_+_4382917 | 9.22 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr14_-_23285011 | 9.17 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chrX_+_123095155 | 9.02 |
ENST00000371160.1
ENST00000435103.1 |
STAG2
|
stromal antigen 2 |
chr1_+_27022839 | 8.96 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr1_+_209941827 | 8.79 |
ENST00000367023.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr1_+_145516560 | 8.74 |
ENST00000537888.1
|
PEX11B
|
peroxisomal biogenesis factor 11 beta |
chr6_+_32938692 | 8.70 |
ENST00000443797.2
|
BRD2
|
bromodomain containing 2 |
chr19_+_16435625 | 8.60 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr1_+_145516252 | 8.56 |
ENST00000369306.3
|
PEX11B
|
peroxisomal biogenesis factor 11 beta |
chr8_+_41347915 | 8.48 |
ENST00000518270.1
ENST00000520817.1 |
GOLGA7
|
golgin A7 |
chr8_+_41348173 | 8.42 |
ENST00000357743.4
|
GOLGA7
|
golgin A7 |
chr5_-_81046922 | 8.39 |
ENST00000514493.1
ENST00000320672.4 |
SSBP2
|
single-stranded DNA binding protein 2 |
chr13_-_31039375 | 8.37 |
ENST00000399494.1
|
HMGB1
|
high mobility group box 1 |
chr6_+_37137939 | 8.37 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr14_-_23285069 | 8.19 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr8_+_41348072 | 8.11 |
ENST00000405786.2
|
GOLGA7
|
golgin A7 |
chr11_-_64512273 | 8.04 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr11_-_64512803 | 8.02 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr3_-_50378343 | 8.00 |
ENST00000359365.4
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1 |
chrX_-_47518498 | 7.99 |
ENST00000335890.2
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone |
chr5_+_32531893 | 7.95 |
ENST00000512913.1
|
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr14_+_50359773 | 7.95 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr14_+_75746340 | 7.93 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr17_+_7210898 | 7.92 |
ENST00000572815.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr14_+_23791159 | 7.90 |
ENST00000557702.1
|
PABPN1
|
poly(A) binding protein, nuclear 1 |
chr4_+_174089904 | 7.88 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
chr12_-_123011536 | 7.88 |
ENST00000331738.7
ENST00000354654.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
chr9_-_86595105 | 7.83 |
ENST00000457156.1
ENST00000360384.5 ENST00000376263.3 |
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K |
chr19_-_41859814 | 7.80 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
chr17_-_48943706 | 7.76 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
chr3_-_50378235 | 7.70 |
ENST00000357043.2
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1 |
chr1_-_153363452 | 7.64 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr5_-_81046904 | 7.61 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
chr1_+_155658849 | 7.56 |
ENST00000368336.5
ENST00000343043.3 ENST00000421487.2 ENST00000535183.1 ENST00000465375.1 ENST00000470830.1 |
DAP3
|
death associated protein 3 |
chr5_-_169725231 | 7.53 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr7_+_50344289 | 7.50 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr14_-_35344093 | 7.48 |
ENST00000382422.2
|
BAZ1A
|
bromodomain adjacent to zinc finger domain, 1A |
chr1_-_154580616 | 7.35 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chrX_+_123095546 | 7.30 |
ENST00000371157.3
ENST00000371145.3 ENST00000371144.3 |
STAG2
|
stromal antigen 2 |
chr6_+_32944119 | 6.99 |
ENST00000606059.1
|
BRD2
|
bromodomain containing 2 |
chr5_-_131826457 | 6.92 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chrX_-_70474910 | 6.87 |
ENST00000373988.1
ENST00000373998.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr9_+_100745615 | 6.87 |
ENST00000339399.4
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
chr3_+_133292574 | 6.84 |
ENST00000264993.3
|
CDV3
|
CDV3 homolog (mouse) |
chr17_-_4852332 | 6.80 |
ENST00000572383.1
|
PFN1
|
profilin 1 |
chr14_+_102228123 | 6.79 |
ENST00000422945.2
ENST00000554442.1 ENST00000556260.2 ENST00000328724.5 ENST00000557268.1 |
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
chr1_-_150208363 | 6.78 |
ENST00000436748.2
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr16_+_21610797 | 6.76 |
ENST00000358154.3
|
METTL9
|
methyltransferase like 9 |
chr10_-_12084770 | 6.73 |
ENST00000357604.5
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast) |
chr1_-_155658085 | 6.73 |
ENST00000311573.5
ENST00000438245.2 |
YY1AP1
|
YY1 associated protein 1 |
chr1_-_226924980 | 6.71 |
ENST00000272117.3
|
ITPKB
|
inositol-trisphosphate 3-kinase B |
chr17_-_7154984 | 6.71 |
ENST00000574322.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr17_-_20370847 | 6.69 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr19_-_39108643 | 6.67 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr1_+_113161778 | 6.63 |
ENST00000263168.3
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1 |
chrX_-_47518527 | 6.62 |
ENST00000333119.3
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone |
chr17_+_65373531 | 6.62 |
ENST00000580974.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr5_+_49963239 | 6.61 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr1_-_53018654 | 6.51 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
chr22_-_32058166 | 6.46 |
ENST00000435900.1
ENST00000336566.4 |
PISD
|
phosphatidylserine decarboxylase |
chr1_+_174769006 | 6.35 |
ENST00000489615.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr2_-_175499294 | 6.34 |
ENST00000392547.2
|
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chr19_-_19754404 | 6.34 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
chr6_+_32940436 | 6.34 |
ENST00000395287.1
|
BRD2
|
bromodomain containing 2 |
chr1_-_151032040 | 6.27 |
ENST00000540998.1
ENST00000357235.5 |
CDC42SE1
|
CDC42 small effector 1 |
chr2_+_30454390 | 6.26 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr9_-_130213652 | 6.23 |
ENST00000536368.1
ENST00000361436.5 |
RPL12
|
ribosomal protein L12 |
chr11_-_76091986 | 6.13 |
ENST00000260045.3
|
PRKRIR
|
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
chr19_-_39108552 | 6.12 |
ENST00000591517.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr14_+_23776167 | 6.11 |
ENST00000554635.1
ENST00000557008.1 |
BCL2L2
BCL2L2-PABPN1
|
BCL2-like 2 BCL2L2-PABPN1 readthrough |
chr6_+_32938665 | 6.06 |
ENST00000374831.4
ENST00000395289.2 |
BRD2
|
bromodomain containing 2 |
chrX_-_119694538 | 6.02 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
chr1_-_150208320 | 6.02 |
ENST00000534220.1
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr16_+_2802623 | 6.02 |
ENST00000576924.1
ENST00000575009.1 ENST00000576415.1 ENST00000571378.1 |
SRRM2
|
serine/arginine repetitive matrix 2 |
chr10_-_88281494 | 5.89 |
ENST00000298767.5
|
WAPAL
|
wings apart-like homolog (Drosophila) |
chr11_-_64512469 | 5.88 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr12_+_94542459 | 5.87 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr8_+_123793633 | 5.85 |
ENST00000314393.4
|
ZHX2
|
zinc fingers and homeoboxes 2 |
chr14_+_23776024 | 5.85 |
ENST00000553781.1
ENST00000556100.1 ENST00000557236.1 ENST00000557579.1 |
BCL2L2-PABPN1
BCL2L2
|
BCL2L2-PABPN1 readthrough BCL2-like 2 |
chr3_+_150321068 | 5.84 |
ENST00000471696.1
ENST00000477889.1 ENST00000485923.1 |
SELT
|
Selenoprotein T |
chr20_+_31407692 | 5.80 |
ENST00000375571.5
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1 |
chr1_-_155658260 | 5.76 |
ENST00000368339.5
ENST00000405763.3 ENST00000368340.5 ENST00000454523.1 ENST00000443231.1 ENST00000347088.5 ENST00000361831.5 ENST00000355499.4 |
YY1AP1
|
YY1 associated protein 1 |
chr4_-_77997126 | 5.74 |
ENST00000537948.1
ENST00000507788.1 ENST00000237654.4 |
CCNI
|
cyclin I |
chr15_+_75074410 | 5.71 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr10_-_120840309 | 5.70 |
ENST00000369144.3
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A |
chr4_+_129730779 | 5.69 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr1_-_183560011 | 5.63 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr3_+_196466710 | 5.62 |
ENST00000327134.3
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2 |
chr20_-_45981138 | 5.59 |
ENST00000446994.2
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr17_-_65241281 | 5.52 |
ENST00000358691.5
ENST00000580168.1 |
HELZ
|
helicase with zinc finger |
chr8_+_29953163 | 5.49 |
ENST00000518192.1
|
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr13_-_31040060 | 5.46 |
ENST00000326004.4
ENST00000341423.5 |
HMGB1
|
high mobility group box 1 |
chr4_+_129730947 | 5.44 |
ENST00000452328.2
ENST00000504089.1 |
PHF17
|
jade family PHD finger 1 |
chr11_-_2323290 | 5.43 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr6_-_24721054 | 5.42 |
ENST00000378119.4
|
C6orf62
|
chromosome 6 open reading frame 62 |
chr6_+_42749759 | 5.38 |
ENST00000314073.5
|
GLTSCR1L
|
GLTSCR1-like |
chr1_+_211433275 | 5.35 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
chr1_-_155658518 | 5.35 |
ENST00000404643.1
ENST00000359205.5 ENST00000407221.1 |
YY1AP1
|
YY1 associated protein 1 |
chr3_-_150320937 | 5.34 |
ENST00000479209.1
|
SERP1
|
stress-associated endoplasmic reticulum protein 1 |
chr5_+_133861790 | 5.32 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
chr14_-_64010046 | 5.32 |
ENST00000337537.3
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform |
chr17_-_7590745 | 5.24 |
ENST00000514944.1
ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53
|
tumor protein p53 |
chr2_-_60780607 | 5.22 |
ENST00000537768.1
ENST00000335712.6 ENST00000356842.4 |
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein) |
chr7_+_26241325 | 5.18 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
chr16_+_21610879 | 5.16 |
ENST00000396014.4
|
METTL9
|
methyltransferase like 9 |
chr19_-_50432782 | 5.16 |
ENST00000413454.1
ENST00000596437.1 ENST00000341114.3 ENST00000595948.1 |
NUP62
IL4I1
|
nucleoporin 62kDa interleukin 4 induced 1 |
chr17_-_56065484 | 5.11 |
ENST00000581208.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
chr1_+_27022485 | 5.08 |
ENST00000324856.7
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr13_-_52027134 | 4.98 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
chr2_-_48132924 | 4.98 |
ENST00000403359.3
|
FBXO11
|
F-box protein 11 |
chr6_-_86352642 | 4.96 |
ENST00000355238.6
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chrX_-_129244655 | 4.96 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr1_+_110163202 | 4.95 |
ENST00000531203.1
ENST00000256578.3 |
AMPD2
|
adenosine monophosphate deaminase 2 |
chr10_-_99094458 | 4.94 |
ENST00000371019.2
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2 |
chr4_-_183838596 | 4.91 |
ENST00000508994.1
ENST00000512766.1 |
DCTD
|
dCMP deaminase |
chr6_-_137113604 | 4.89 |
ENST00000359015.4
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5 |
chr17_-_27418537 | 4.88 |
ENST00000408971.2
|
TIAF1
|
TGFB1-induced anti-apoptotic factor 1 |
chr16_+_718086 | 4.87 |
ENST00000315082.4
ENST00000563134.1 |
RHOT2
|
ras homolog family member T2 |
chr10_+_104535994 | 4.87 |
ENST00000369889.4
|
WBP1L
|
WW domain binding protein 1-like |
chr12_-_57522813 | 4.83 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr1_-_155658766 | 4.81 |
ENST00000295566.4
ENST00000368330.2 |
YY1AP1
|
YY1 associated protein 1 |
chr5_+_115177178 | 4.78 |
ENST00000316788.7
|
AP3S1
|
adaptor-related protein complex 3, sigma 1 subunit |
chr19_-_47220335 | 4.75 |
ENST00000601806.1
ENST00000593363.1 ENST00000598633.1 ENST00000595515.1 ENST00000433867.1 |
PRKD2
|
protein kinase D2 |
chr17_-_7155274 | 4.74 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr12_-_123011476 | 4.73 |
ENST00000528279.1
ENST00000344591.4 ENST00000526560.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
chr14_+_23790690 | 4.68 |
ENST00000556821.1
|
PABPN1
|
poly(A) binding protein, nuclear 1 |
chr7_+_114562172 | 4.65 |
ENST00000393486.1
ENST00000257724.3 |
MDFIC
|
MyoD family inhibitor domain containing |
chr2_-_60780702 | 4.52 |
ENST00000359629.5
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein) |
chr8_+_29952914 | 4.51 |
ENST00000321250.8
ENST00000518001.1 ENST00000520682.1 ENST00000442880.2 ENST00000523116.1 |
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr3_-_182698381 | 4.50 |
ENST00000292782.4
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1 |
chr10_+_31608054 | 4.48 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
chr14_+_92980111 | 4.44 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr1_-_150208291 | 4.44 |
ENST00000533654.1
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr1_-_167906277 | 4.43 |
ENST00000271373.4
|
MPC2
|
mitochondrial pyruvate carrier 2 |
chr7_+_26241310 | 4.43 |
ENST00000396386.2
|
CBX3
|
chromobox homolog 3 |
chr6_-_79944336 | 4.42 |
ENST00000344726.5
ENST00000275036.7 |
HMGN3
|
high mobility group nucleosomal binding domain 3 |
chr4_-_183838372 | 4.42 |
ENST00000503820.1
ENST00000503988.1 |
DCTD
|
dCMP deaminase |
chr2_+_178077477 | 4.41 |
ENST00000411529.2
ENST00000435711.1 |
HNRNPA3
|
heterogeneous nuclear ribonucleoprotein A3 |
chr1_-_23670813 | 4.40 |
ENST00000374612.1
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chr14_-_65569186 | 4.38 |
ENST00000555932.1
ENST00000358664.4 ENST00000284165.6 ENST00000358402.4 ENST00000246163.2 ENST00000556979.1 ENST00000555667.1 ENST00000557746.1 ENST00000556443.1 |
MAX
|
MYC associated factor X |
chr9_+_2015335 | 4.36 |
ENST00000349721.2
ENST00000357248.2 ENST00000450198.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr10_-_103880209 | 4.34 |
ENST00000425280.1
|
LDB1
|
LIM domain binding 1 |
chr17_+_30264014 | 4.34 |
ENST00000322652.5
ENST00000580398.1 |
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit |
chr18_-_53255766 | 4.34 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr10_+_70091847 | 4.30 |
ENST00000441000.2
ENST00000354695.5 |
HNRNPH3
|
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
chr17_+_43299156 | 4.29 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr11_+_10476851 | 4.29 |
ENST00000396553.2
|
AMPD3
|
adenosine monophosphate deaminase 3 |
chr10_+_114710211 | 4.29 |
ENST00000349937.2
ENST00000369397.4 |
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr1_-_23670817 | 4.26 |
ENST00000478691.1
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chr19_-_33166045 | 4.25 |
ENST00000586693.3
ENST00000587352.1 ENST00000586463.1 ENST00000306065.4 |
ANKRD27
|
ankyrin repeat domain 27 (VPS9 domain) |
chr11_+_66384053 | 4.24 |
ENST00000310137.4
ENST00000393979.3 ENST00000409372.1 ENST00000443702.1 ENST00000409738.4 ENST00000514361.3 ENST00000503028.2 ENST00000412278.2 ENST00000500635.2 |
RBM14
RBM4
RBM14-RBM4
|
RNA binding motif protein 14 RNA binding motif protein 4 RBM14-RBM4 readthrough |
chr1_-_155224751 | 4.23 |
ENST00000350210.2
ENST00000368368.3 |
FAM189B
|
family with sequence similarity 189, member B |
chr1_-_183559693 | 4.21 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr9_-_35650900 | 4.21 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
chr6_+_30297306 | 4.17 |
ENST00000420746.1
ENST00000513556.1 |
TRIM39
TRIM39-RPP21
|
tripartite motif containing 39 TRIM39-RPP21 readthrough |
chr19_-_2050852 | 4.08 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr10_+_21823079 | 4.08 |
ENST00000377100.3
ENST00000377072.3 ENST00000446906.2 |
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr2_+_182321925 | 4.08 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr6_+_111195973 | 4.04 |
ENST00000368885.3
ENST00000368882.3 ENST00000451850.2 ENST00000368877.5 |
AMD1
|
adenosylmethionine decarboxylase 1 |
chr16_+_88872176 | 4.03 |
ENST00000569140.1
|
CDT1
|
chromatin licensing and DNA replication factor 1 |
chr1_-_23670752 | 4.02 |
ENST00000302271.6
ENST00000426846.2 ENST00000427764.2 ENST00000606561.1 ENST00000374616.3 |
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chrX_+_109245863 | 3.98 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
chr14_+_90864504 | 3.97 |
ENST00000544280.2
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
chr1_-_151431909 | 3.96 |
ENST00000361398.3
ENST00000271715.2 |
POGZ
|
pogo transposable element with ZNF domain |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 52.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
7.3 | 29.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
6.8 | 20.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
5.4 | 16.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
4.3 | 17.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.3 | 12.9 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
3.6 | 17.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
3.6 | 25.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.5 | 13.8 | GO:0002840 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
3.4 | 3.4 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
3.0 | 18.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
3.0 | 23.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.9 | 17.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
2.9 | 8.6 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.8 | 14.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
2.5 | 40.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.5 | 17.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.5 | 7.4 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
2.2 | 15.7 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
2.1 | 8.6 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.1 | 14.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.1 | 16.6 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
2.0 | 7.8 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.0 | 7.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.9 | 5.7 | GO:0002188 | formation of cytoplasmic translation initiation complex(GO:0001732) translation reinitiation(GO:0002188) |
1.8 | 5.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.7 | 5.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oxidative stress-induced premature senescence(GO:0090403) oligodendrocyte apoptotic process(GO:0097252) |
1.7 | 6.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
1.7 | 18.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.7 | 10.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
1.6 | 6.3 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
1.5 | 8.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.5 | 13.2 | GO:0072718 | response to cisplatin(GO:0072718) |
1.4 | 7.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.4 | 5.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.3 | 4.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.3 | 4.0 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
1.3 | 4.0 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.3 | 3.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
1.3 | 2.6 | GO:0061010 | gall bladder development(GO:0061010) |
1.3 | 3.8 | GO:2001160 | regulation of genetic imprinting(GO:2000653) regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
1.3 | 6.3 | GO:2000035 | positive regulation of somatic stem cell population maintenance(GO:1904674) regulation of stem cell division(GO:2000035) |
1.2 | 12.4 | GO:0032264 | IMP salvage(GO:0032264) |
1.2 | 8.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.2 | 3.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
1.1 | 5.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.1 | 7.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
1.1 | 2.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.1 | 4.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 5.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.0 | 23.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 4.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.0 | 6.7 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) common myeloid progenitor cell proliferation(GO:0035726) |
0.9 | 5.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.9 | 5.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.9 | 45.9 | GO:0043486 | histone exchange(GO:0043486) |
0.9 | 2.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.9 | 3.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.9 | 1.7 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.9 | 6.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.8 | 9.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.8 | 10.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.8 | 3.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.8 | 4.9 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.8 | 4.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 3.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.8 | 2.4 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.8 | 3.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 3.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.8 | 12.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 17.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 12.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.7 | 5.0 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.7 | 12.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.7 | 2.1 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.7 | 1.4 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.7 | 2.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.7 | 10.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.6 | 3.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 1.9 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.6 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 2.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.6 | 4.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 2.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.6 | 11.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 4.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 3.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 47.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.5 | 2.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 2.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.5 | 3.0 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.5 | 4.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 5.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 2.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 9.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 1.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 1.0 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.5 | 2.3 | GO:0044336 | embryonic genitalia morphogenesis(GO:0030538) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 2.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 18.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 3.7 | GO:0010571 | double-strand break repair via break-induced replication(GO:0000727) positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 2.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 7.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.5 | 4.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 1.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.4 | 7.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 2.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 1.8 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.4 | 0.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 2.1 | GO:1903751 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 2.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.4 | 7.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 2.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 2.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 1.6 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
0.4 | 1.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.4 | 6.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 5.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 2.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 1.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 1.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 6.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 3.9 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.1 | GO:0050894 | determination of affect(GO:0050894) |
0.4 | 2.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.4 | 7.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 5.7 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.3 | 7.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.3 | 1.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 2.3 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.3 | 4.8 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 2.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 4.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 6.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.3 | 0.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 4.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 2.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 2.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 2.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 2.8 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 3.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.3 | 2.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 3.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 2.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 1.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.3 | 6.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 5.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 5.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 4.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 6.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 8.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 20.0 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 4.6 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.2 | 3.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.2 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 1.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 5.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.8 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 6.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.7 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 4.9 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 3.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 5.9 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 1.9 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 1.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 14.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 1.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 8.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.3 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.2 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 2.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 6.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 4.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 3.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.1 | 1.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 9.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 2.8 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 1.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 4.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 2.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 3.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 4.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 3.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 7.6 | GO:0070126 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.1 | 13.9 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.1 | 3.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 1.7 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.9 | GO:0097012 | serotonin metabolic process(GO:0042428) cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 1.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 3.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 28.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 5.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.0 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 3.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 6.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 1.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.8 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 14.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 3.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 4.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 6.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 7.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 8.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 1.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.7 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 2.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 2.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.7 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 3.9 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.2 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 2.0 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.9 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 5.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 1.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 3.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 2.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 1.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 1.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 4.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 3.1 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
0.0 | 1.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 1.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 1.5 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 1.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.8 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.0 | 0.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 1.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
4.2 | 50.1 | GO:0005642 | annulate lamellae(GO:0005642) |
3.9 | 7.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.6 | 25.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
2.5 | 17.5 | GO:0097452 | GAIT complex(GO:0097452) |
2.4 | 19.6 | GO:0035976 | AP1 complex(GO:0035976) |
1.8 | 37.3 | GO:0000812 | Swr1 complex(GO:0000812) |
1.7 | 12.0 | GO:0072487 | MSL complex(GO:0072487) |
1.6 | 25.2 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
1.5 | 9.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.5 | 7.5 | GO:0036398 | TCR signalosome(GO:0036398) |
1.5 | 7.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.4 | 2.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.2 | 17.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.2 | 9.8 | GO:0032010 | phagolysosome(GO:0032010) |
1.2 | 4.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.2 | 16.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.0 | 4.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.0 | 5.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.9 | 6.6 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 11.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 4.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 2.5 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.8 | 18.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.8 | 6.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 5.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.7 | 4.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.7 | 5.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 17.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.7 | 7.9 | GO:0090543 | Flemming body(GO:0090543) |
0.6 | 5.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 5.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 3.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 3.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.6 | 33.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.6 | 5.1 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 5.0 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 6.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 4.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 14.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.5 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 3.1 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 47.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.4 | 4.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 44.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 1.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 1.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.4 | 12.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.0 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.3 | 1.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.3 | 1.6 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 3.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 34.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.3 | 7.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 4.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 6.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 4.3 | GO:0032059 | bleb(GO:0032059) |
0.2 | 4.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 3.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 7.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 43.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.2 | 5.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 6.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 6.3 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 1.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 3.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 3.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 4.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 5.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 8.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 3.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 17.0 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 8.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 14.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 12.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 12.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 2.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 3.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 8.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 2.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 23.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 2.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 2.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 3.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 8.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 7.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 17.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 5.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 3.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) apical junction complex(GO:0043296) |
0.0 | 7.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 3.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 3.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 3.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.4 | GO:0015030 | Cajal body(GO:0015030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.4 | 52.2 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
3.9 | 15.7 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
2.9 | 29.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.5 | 7.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.4 | 12.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.3 | 13.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.2 | 23.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.2 | 6.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.8 | 7.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.8 | 14.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.7 | 25.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.7 | 5.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.6 | 6.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.6 | 17.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.5 | 7.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.4 | 4.2 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
1.4 | 12.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 51.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.3 | 23.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.2 | 21.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 9.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 6.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.1 | 15.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.1 | 9.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 18.0 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 9.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 13.6 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.9 | 16.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.9 | 8.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 2.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.8 | 44.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.8 | 7.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 8.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 6.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 6.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 2.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.8 | 10.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 3.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.7 | 3.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 8.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 4.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 10.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 2.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.7 | 3.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 5.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 1.9 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.6 | 17.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 2.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.6 | 4.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 6.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 16.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 33.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.6 | 11.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 10.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 6.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 5.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.6 | 1.7 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.6 | 14.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 6.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 28.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 7.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 4.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) protein antigen binding(GO:1990405) |
0.5 | 3.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 28.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 1.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.4 | 3.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 2.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 3.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 7.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 22.2 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 17.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 2.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 6.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 2.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 3.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 46.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.3 | 2.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 5.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.3 | 1.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.3 | 6.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 5.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 2.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 2.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.3 | 6.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 10.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 4.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 0.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 2.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 3.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 13.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 1.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 2.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 1.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 4.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 2.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 1.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 5.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 10.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 5.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 9.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 9.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 5.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 8.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 3.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 2.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 5.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 9.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 6.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 2.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 6.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 6.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 5.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 4.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 4.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 3.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 4.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.1 | GO:0005501 | retinoic acid binding(GO:0001972) retinoid binding(GO:0005501) isoprenoid binding(GO:0019840) |
0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 2.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 2.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.4 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 4.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 2.5 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 3.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 7.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 2.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 1.6 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 9.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 1.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 1.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 1.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 1.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 9.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 25.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.7 | 51.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.4 | 35.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 19.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 28.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 6.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 36.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 13.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 14.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 32.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 55.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 9.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 17.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 5.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 22.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 3.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 6.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 13.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 16.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 5.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 11.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 4.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 16.1 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 19.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 11.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 7.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 5.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 5.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 7.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 15.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 5.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 6.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 4.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 4.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 5.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 7.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 4.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 55.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.1 | 5.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 22.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 17.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.9 | 25.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 15.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 17.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 12.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 24.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 15.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 17.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 7.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 2.4 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.4 | 15.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 17.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 21.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 7.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 4.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 9.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 8.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 7.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 24.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 44.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.3 | 6.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 7.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 7.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 4.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 4.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 8.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 38.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 5.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 10.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 8.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 5.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 6.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 11.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 4.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 6.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 5.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 6.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 5.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 2.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 8.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 4.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 1.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 5.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |